NATURE COMMUNICATIONS
At-home wearables and machine learning sensitively capture disease progression in amyotrophic lateral sclerosis
Related Posts
Duke study shows path forward for trials targeting the gut microbiome in ALS
Duke study shows path forward for trials targeting the gut microbiome in ALS
Gretchen SimoneauxApril 22, 2025
Riluzole, Edaravone, and Tofersen: The Approved Drugs for ALS Progression
Riluzole, Edaravone, and Tofersen: The Approved Drugs for ALS Progression
Gretchen SimoneauxApril 16, 2025
A Better Drug May Make Transplants More Successful
A Better Drug May Make Transplants More Successful
Gretchen SimoneauxNovember 1, 2024
